Analyst Arlinda Lee works at GOLDMAN SACHS and is focused on Healthcare, Consumer Cyclical sectors with 188 price targets and ratings documented since 2015 spanning on 19 stocks. Analyst's average stock valuation to be materialised ratio is 65.07% with an average time for price targets to be met of 165.06 days.
Most recent stock forecast was given on VOD, at 14-Dec-2022.
Arlinda Lee best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for BNTX (BIONTECH SE SPONSORED ADR) at 7/21/2020. The price target of $97 was fulfilled within 1 day with a profit of $6.6 (7.3%) receiving and performance score of 73.01.
Average potential price target upside
Currently, out of the existing stock ratings of Arlinda Lee - 10719 which are a Buy (83.59%), 1709 which are a Hold (13.33%), 396 which are a Sell (3.09%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
57
$36.83 (182.60%)
57
27 days ago
3/7 (42.86%)
$19.36 (79.72%)
146
Buy
67
$46.83 (232.18%)
72
27 days ago
0/6 (0%)
$40.64 (131.63%)
Buy
48
$27.83 (137.98%)
37
4 months 18 days ago
5/9 (55.56%)
$18.14 (83.78%)
296
Buy
46
$25.83 (128.06%)
70
4 months 19 days ago
2/5 (40%)
$18.35 (50.62%)
95
Hold
45
$24.83 (123.10%)
45
6 months 16 days ago
1/3 (33.33%)
$10.85 (35.43%)
24
